Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

2.

New study links air pollution with higher rates of head and neck cancer

3.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

4.

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

5.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot